APGE
Price
$41.84
Change
-$0.60 (-1.41%)
Updated
Jun 12, 04:59 PM (EDT)
Capitalization
2.47B
81 days until earnings call
DAN
Price
$17.38
Change
-$0.33 (-1.86%)
Updated
Jun 12, 04:59 PM (EDT)
Capitalization
1.83B
48 days until earnings call
Interact to see
Advertisement

APGE vs DAN

Header iconAPGE vs DAN Comparison
Open Charts APGE vs DANBanner chart's image
Apogee Therapeutics
Price$41.84
Change-$0.60 (-1.41%)
Volume$12.64K
Capitalization2.47B
Dana
Price$17.38
Change-$0.33 (-1.86%)
Volume$49.57K
Capitalization1.83B
APGE vs DAN Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. DAN commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and DAN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (APGE: $42.44 vs. DAN: $17.38)
Brand notoriety: APGE and DAN are both not notable
APGE represents the Biotechnology, while DAN is part of the Auto Parts: OEM industry
Current volume relative to the 65-day Moving Average: APGE: 189% vs. DAN: 154%
Market capitalization -- APGE: $2.44B vs. DAN: $1.83B
APGE [@Biotechnology] is valued at $2.44B. DAN’s [@Auto Parts: OEM] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The market cap for tickers in the [@Auto Parts: OEM] industry ranges from $52.56B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B. The average market capitalization across the [@Auto Parts: OEM] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileDAN’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • DAN’s FA Score: 1 green, 4 red.
According to our system of comparison, DAN is a better buy in the long-term than APGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while DAN’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 2 bearish.
  • DAN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than DAN.

Price Growth

APGE (@Biotechnology) experienced а +16.27% price change this week, while DAN (@Auto Parts: OEM) price change was +5.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.06%. For the same industry, the average monthly price growth was +16.41%, and the average quarterly price growth was +7.21%.

The average weekly price growth across all stocks in the @Auto Parts: OEM industry was +2.87%. For the same industry, the average monthly price growth was +3.66%, and the average quarterly price growth was +8.39%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

DAN is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Auto Parts: OEM (+2.87% weekly)

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.48B) has a higher market cap than DAN($1.83B). DAN YTD gains are higher at: 52.361 vs. APGE (-6.313). DAN has higher annual earnings (EBITDA): 748M vs. APGE (-216.68M). DAN (529M) and APGE (521M) have equal amount of cash in the bank . APGE has less debt than DAN: APGE (11.8M) vs DAN (2.98B). DAN has higher revenues than APGE: DAN (10.6B) vs APGE (0).
APGEDANAPGE / DAN
Capitalization2.48B1.83B135%
EBITDA-216.68M748M-29%
Gain YTD-6.31352.361-12%
P/E RatioN/A48.62-
Revenue010.6B-
Total Cash521M529M98%
Total Debt11.8M2.98B0%
FUNDAMENTALS RATINGS
DAN: Fundamental Ratings
DAN
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEDAN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWGX87.190.33
+0.38%
American Funds New World R6
PRLAX20.13N/A
N/A
T. Rowe Price Latin America
FOCSX17.30N/A
N/A
Fidelity Small Cap Growth K6
IRSYX15.52N/A
N/A
Macquarie Real Estate Securities Y
EPLPX21.80-0.03
-0.14%
NYLI Epoch U.S. Equity Yield Class A

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.00%
SYRE - APGE
53%
Loosely correlated
-3.02%
CRNX - APGE
52%
Loosely correlated
-2.27%
ERAS - APGE
52%
Loosely correlated
-5.59%
KRYS - APGE
51%
Loosely correlated
+1.02%
ATXS - APGE
51%
Loosely correlated
+1.40%
More